tiprankstipranks
Venture Life Group PLC (GB:VLG)
LSE:VLG

Venture Life (VLG) Share Price & Analysis

0 Followers

VLG Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range27.00p - 44.00p
Previous Close38.25p
Volume188.70K
Average Volume (3M)206.13K
Market Cap
£49.65M
Enterprise Value70.87M
Total Cash (Recent Filing)£5.63M
Total Debt (Recent Filing)£26.85M
Price to Earnings (P/E)57.2
Beta0.57
Sep 19, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding125,831,530
10 Day Avg. Volume513,404
30 Day Avg. Volume206,126
Standard Deviation0.13
R-Squared0.00202
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-16.27
Price to Sales (P/S)328.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

6.36%0.00%0.00%93.64%
0.00% Other Institutional Investors
93.64% Public Companies and
Individual Investors

VLG FAQ

What was Venture Life Group PLC’s price range in the past 12 months?
Venture Life Group PLC lowest share price was 27.00p and its highest was 44.00p in the past 12 months.
    What is Venture Life Group PLC’s market cap?
    Currently, no data Available
    When is Venture Life Group PLC’s upcoming earnings report date?
    Venture Life Group PLC’s upcoming earnings report date is Sep 19, 2024 which is in 147 days.
      How were Venture Life Group PLC’s earnings last quarter?
      Venture Life Group PLC released its earnings results on Apr 09, 2024. The company reported 0.019p earnings per share for the quarter, beating the consensus estimate of N/A by 0.019p.
        Is Venture Life Group PLC overvalued?
        According to Wall Street analysts Venture Life Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Venture Life Group PLC pay dividends?
          Venture Life Group PLC pays a Annually dividend of 0p which represents an annual dividend yield of N/A. See more information on Venture Life Group PLC dividends here
            What is Venture Life Group PLC’s EPS estimate?
            Venture Life Group PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Venture Life Group PLC have?
            Venture Life Group PLC has 126,498,200 shares outstanding.
              What happened to Venture Life Group PLC’s price movement after its last earnings report?
              Venture Life Group PLC reported an EPS of 0.019p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.185%.
                Which hedge fund is a major shareholder of Venture Life Group PLC?
                Currently, no hedge funds are holding shares in GB:VLG
                ---

                Venture Life Stock Smart Score

                5
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                -7.42%
                12-Months-Change

                Fundamentals

                Return on Equity
                1.21%
                Trailing 12-Months
                Asset Growth
                -4.62%
                Trailing 12-Months

                Company Description

                Venture Life Group PLC

                Venture Life Group PLC is an international consumer self-care company. The company focuses on developing, manufacturing and commercializing products for the aging population. Its products include Oral Healthcare, Proctology, Dermatology, Neurology, and Women's Healthcare. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements; and Development and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. It earns a vast majority of its revenue from the Development and Manufacturing segment in the United Kingdom. Geographically, it also operates in Italy, Switzerland, and other regions.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                ANGLE plc
                Genedrive
                EKF Diagnostics Holdings
                C4X Discovery Holdings
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis